Log in to MyACC
Renal Denervation: A Workshop for the Hypertension Care Team
Registration for this event is now closed.
If you wish to join the waitlist, please contact jsalas@acc.org.
Course Overview
Make plans to attend Renal Denervation for Hypertension: A Care Pathway Workshop for the Heart Care Team on Friday, April 5, 2024. This educational program will provide the opportunity for an update on the latest science on contemporary approaches to hypertension management and to understand how renal denervation may impact hypertension management and overall patient care.
Exclusive to members of the ACC Federal Cardiology Section.
Statement of Need
Hypertension is the leading cause of cardiovascular disease, premature death, and disability-adjusted life years in the world, but it remains uncontrolled for a majority of people. Innovative and emerging treatment options have an important role in controlling hypertension. One advance in treatment is adjunctive renal denervation (RDN). As new data continues to emerge, clinicians will need education on the safety and efficacy of renal denervation from recent trials demonstrating its benefit as an emerging treatment.
Goal
The overall goal is to improve hypertension management and overall patient care by providing an update on the latest science on contemporary approaches to hypertension management and understanding how renal denervation may impact hypertension management and overall patient care.
Target Audience
Members of ACC's Federal Cardiology Member Section.
Learning Objectives:
Upon completion of this program, attendees should be able to:
- Analyze the latest trials and updates in science in renal denervation as an innovative approach to hypertension management.
- Evaluate a hypertension management plan including considering appropriate renal denervation options.
- Explain how renal denervation may impact the approach to hypertension management and overall patient care in the federal system.
Kreton Mavromatis, MD, FACC
Mladen Vidovich, MD, FACC
Taisei Kobayashi, MD, FACC
Rajesh Swaminathan, MD, FACC
Thomas Todoran, MD, FACC
Debbie Cohen, MD
Antonio Gutierrez, MD
Disclosure/Conflict of Interest Statement
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity, and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.
ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.
ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.
ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.
Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians
The ACCF designates this internet enduring material for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The ACCF designates this educational activity for a maximum of 3.75 continuing nursing education contact hours.
Interprofessional Continuing Education (ICPE) Credit
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Maintenance of Certification (MOC) Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
